Overseen ByScott McCardle, MD
Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Phase 2 & 3
Waitlist Available
Sponsor: TriHealth Inc.
Prior Safety Data
Trial Summary
What is the purpose of this trial?This is a double-blind, randomized, placebo-controlled trial to examine the effectiveness of adding one 25mg dose of naloxegol to the cardiac surgery pre-operative regimen.
Eligibility Criteria
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: NaloxegolExperimental Treatment1 Intervention
naloxegol 25 mg pill
Group II: PlaceboPlacebo Group1 Intervention
placebo pill
Find A Clinic Near You
Research locations nearbySelect from list below to view details:
Bethesda North TriHealth HospitalCincinnati, OH
Loading ...
Who is running the clinical trial?
TriHealth Inc.Lead Sponsor